** Shares of X-ray products maker VREX.O jump 11.8% to
$30.02
** Company on Tuesday after market close reported Q4 rev of
$226 mln, beating Refinitiv IBES est of $215.5 mln, driven by
strength in both its medical and industrial units urn:newsml:reuters.com:*:nBw9HPV5Ga
** Reports profit of $8.8 mln vs loss of $26.2 mln a year
earlier, as co recorded lower expenses in the quarter
** Co's Q4 adj profit of 45 cents/shr also tops est 37
cents/shr
** Co has beat earnings estimates for the past four quarters
as well, according to Refinitiv IBES
** Current avg recommendation of 4 analysts on stock is
"buy"; their median PT is $38 - Refinitiv data
** YTD, stock up ~80% including session's gains
(Reporting by Amruta Khandekar)
((Amruta.Khandekar@thomsonreuters.com;))